SUSRF (Surgical Science Sweden AB) Total Stockholders Equity: $473.9 Mil (As of Mar. 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

SUSRF Surgical Science Sweden AB SUSRF
85 GF Score
Price $4.00
GF Value $19.89
! 4 Warning Signs
View Full Analysis

What is Surgical Science Sweden AB Total Stockholders Equity?

Surgical Science Sweden AB SUSRF -2.20% 85 Total Stockholders Equity is $473.9 Mil as of Mar. 2026. GuruFocus rates SUSRF with a GF Score™ of 85/100 and a GF Value™ of $19.89. The stock has 4 warning signs investors should review.

Surgical Science Sweden AB's Total Stockholders Equity for the quarter that ended in Mar. 2026 was $473.9 Mil. It refers to the net assets owned by shareholders. It does not include minority interest.

Total Stockholders Equity is used to calculate Book Value per Share. Surgical Science Sweden AB's Book Value per Share for the quarter that ended in Mar. 2026 was $9.29. The ratio of a company's debt over equity can be used to measure how leveraged this company is. Surgical Science Sweden AB's Debt-to-Equity for the quarter that ended in Mar. 2026 was 0.00.

Surgical Science Sweden AB  (OTCPK:SUSRF) Total Stockholders Equity Explanation

1. Total Stockholders Equity is used to calculate Book Value per Share.

Surgical Science Sweden AB's Book Value per Share for the quarter that ended in Mar. 2026 is

Book Value per Share=(Total Stockholders Equity-Preferred Stock)/Shares Outstanding (EOP)
=(473.91-0)/51.026
=9.29

2. The ratio of a company's debt over equity can be used to measure how leveraged this company is.

Surgical Science Sweden AB's Debt-to-Equity for the quarter that ended in Mar. 2026 is

Debt-to-Equity=Total Debt / Total Stockholders Equity
=(Short-Term Debt & Capital Lease Obligation + Long-Term Debt & Capital Lease Obligation) / Total Stockholders Equity
=(0.23 + 0) / 473.91
=0.00

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Surgical Science Sweden AB Total Stockholders Equity Related Terms

Surgical Science Sweden AB Total Stockholders Equity Historical Data

* Premium members only.

The historical data trend for Surgical Science Sweden AB's Total Stockholders Equity can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Surgical Science Sweden AB Total Stockholders Equity Chart

Surgical Science Sweden AB Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
Total Stockholders Equity
Get a 7-Day Free Trial Premium Member Only Premium Member Only 394.42 408.22 423.61 439.57 459.79

Surgical Science Sweden AB Quarterly Data
Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26
Total Stockholders Equity Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 441.80 451.13 458.77 459.79 473.91
SUSRF
85GF Score
Surgical Science Sweden AB SUSRF
Total Stockholders Equity is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis
What does a Total Stockholders Equity of $473.9 Mil mean?
Surgical Science Sweden AB (SUSRF) has a Total Stockholders Equity of $473.9 Mil as of Mar. 2026. The total amount of shareholder's equity as recorded on a company's balance sheet. View historical data for Surgical Science Sweden AB and its competitors.
Is Surgical Science Sweden AB's Total Stockholders Equity too high?
Surgical Science Sweden AB's current Total Stockholders Equity is $473.9 Mil. Overall, Surgical Science Sweden AB has a GF Score™ of 85/100, reflecting its overall financial health beyond just this single metric.
How does Surgical Science Sweden AB's Total Stockholders Equity compare to VEEV and BTSG?
Surgical Science Sweden AB's Total Stockholders Equity of $473.9 Mil can be compared against companies in the Healthcare Providers & Services industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Total Stockholders Equity for a Healthcare Providers & Services company?
A good Total Stockholders Equity depends on the Healthcare Providers & Services industry context. However, Total Stockholders Equity should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Total Stockholders Equity mean?
A high Total Stockholders Equity can signal that a stock is expensive relative to its fundamentals. The total amount of shareholder's equity as recorded on a company's balance sheet. View historical data for Surgical Science Sweden AB and its competitors. Surgical Science Sweden AB's current Total Stockholders Equity is $473.9 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Surgical Science Sweden AB stock overvalued right now?
Surgical Science Sweden AB (SUSRF) has a current Total Stockholders Equity of $473.9 Mil. The stock's GF Value™ is $19.89, compared to a current price of $4.00 — trading 79.9% below its estimated fair value. The current Total Stockholders Equity is $473.9 Mil. Surgical Science Sweden AB's overall GF Score™ is 85/100 with 4 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Total Stockholders Equity calculated?
Total Stockholders Equity is calculated from a company's financial statements. For Surgical Science Sweden AB (SUSRF), the current Total Stockholders Equity is $473.9 Mil as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Surgical Science Sweden AB (SUSRF) Overvalued in 2026?

Based on GuruFocus' analysis, Surgical Science Sweden AB stock appears to be undervalued. The current stock price of $4.00 is trading 79.9% below its estimated GF Value™ of $19.89.

Key valuation signals for SUSRF:

  • Total Stockholders Equity: $473.9 Mil
  • GF Value™: $19.89 vs. price of $4.00 (79.9% below fair value)
  • GF Score™: 85/100 with 4 warning signs

No single metric tells the full story. See the SUSRF stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Surgical Science Sweden AB Business Description

Other Exchanges SUS:Sweden4P41:Germany
Address Drakegatan 7A, Gothenburg, SWE, SE-412 50
Surgical Science Sweden AB is a supplier of virtual reality simulators for medical training. The company's core is its proprietary software and hardware for simulating interactions between instruments and anatomy. It has two operating segments: Educational products include Proprietary brand medical simulator hardware and software for generic training of psycho-motor skills, instrument handling, and training for a large number of procedures and examinations prior to entering the clinical environment, as well as support and services. Industry/OEM includes simulation software for product-specific training of surgeons in robot-assisted surgery and other digitalized medical instruments, and also simulators for medical device companies.
85GF Score

Get the complete analysis for SUSRF

Total Stockholders Equity is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

$4.00
Price
$19.89
GF Value